[1]
Ali I, Mukhtar SD, Ali HS, Scotti MT, Scotti L. Advances in nanoparticles as anticancer drug delivery vector: need of this century. Curr Pharm Des 2020; 26(15): 1637-49.
[2]
Lather A, Sharma S, Khatkar S, Khatkar A. Docking related survey on heterocyclic compounds based on glucosamine-6-phosphate synthase inhibitors and their antimicrobial potential. Curr Pharm Des 2020; 26(15): 1650-65.
[3]
Roy H, Nayak BS, Nandi S. Chitosan anchored nanoparticles in current drug development utilizing computer-aided pharmacokinetic modeling: case studies for target specific cancer treatment and future prospective. Curr Pharm Des 2020; 26(15): 1666-75.
[4]
Gul S, Khalil R, Ul-Haq Z, Mubarak MS. Computational overview of mycobacterial thymidine monophosphate kinase. Curr Pharm Des 2020; 26(15): 1676-81.
Current Pharmaceutical Design
Title:Recent Advancement in Computer-Aided Drug Design
Volume: 26 Issue: 15
Author(s): Luciana Scotti and Marcus Tullius Scotti
Affiliation:
Export Options
About this article
Cite this article as:
Scotti Luciana and Scotti Tullius Marcus, Recent Advancement in Computer-Aided Drug Design, Current Pharmaceutical Design 2020; 26 (15) . https://dx.doi.org/10.2174/138161282615200518092124
DOI https://dx.doi.org/10.2174/138161282615200518092124 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
23
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]
Current Pharmaceutical Design Disrupted Structural Brain Network in AD and aMCI: A Finding of Long Fiber Degeneration
Current Alzheimer Research Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer’s Disease Patients
Current Alzheimer Research Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice
Current Alzheimer Research Protective Effects of the Caffeine Against Neurodegenerative Diseases
Current Medicinal Chemistry Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
Current Drug Targets Action Mechanisms of Chinese Herbal Compound at the Molecular Level
Letters in Drug Design & Discovery Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease
Current Pharmaceutical Design Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Cannabinoids
Current Drug Targets - CNS & Neurological Disorders The Emerging Role of Coenzyme Q-10 in Aging, Neurodegeneration, Cardiovascular Disease, Cancer and Diabetes Mellitus
Current Neurovascular Research An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets Strategies to Improve the Killing of Tumors Using Temozolomide: Targeting the DNA Repair Protein MGMT
Current Medicinal Chemistry Cross-Cultural Comparison of Mild Cognitive Impairment between China and USA
Current Alzheimer Research Activation of Kir2.3 Channels by Tenidap Suppresses Epileptiform Burst Discharges in Cultured Hippocampal Neurons
CNS & Neurological Disorders - Drug Targets Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach
CNS & Neurological Disorders - Drug Targets Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia
CNS & Neurological Disorders - Drug Targets